Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8BI8

Structure of a cyclic beta-hairpin peptide derived from neuronal nitric oxide synthase

Summary for 8BI8
Entry DOI10.2210/pdb8bi8/pdb
DescriptorNitric oxide synthase, brain (2 entities in total)
Functional Keywordscyclic beta-hairpin, neuronal nitric oxidase synthase, inhibitor of the nos/psd-95 interaction, peptide drugs, stroke treatment, protein binding
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight4977.45
Authors
Balboa, J.R.,Ostergaard, S.,Stromgaard, K.,Knapp, S.,Joerger, A.C.,Structural Genomics Consortium (SGC) (deposition date: 2022-11-01, release date: 2022-12-21, Last modification date: 2024-11-13)
Primary citationBalboa, J.R.,Essig, D.J.,Ma, S.,Karer, N.,Clemmensen, L.S.,Pedersen, S.W.,Joerger, A.C.,Knapp, S.,Ostergaard, S.,Stromgaard, K.
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction.
J.Med.Chem., 66:976-990, 2023
Cited by
PubMed Abstract: The complex between the -methyl-d-aspartate receptor (NMDAR), neuronal nitric oxide synthase (nNOS), and the postsynaptic density protein-95 (PSD-95) is an attractive therapeutic target for the treatment of acute ischemic stroke. The complex is formed via the PDZ protein domains of PSD-95, and efforts to disrupt the complex have generally been based on C-terminal peptides derived from the NMDAR. However, nNOS binds PSD-95 through a β-hairpin motif, providing an alternative starting point for developing PSD-95 inhibitors. Here, we designed a cyclic nNOS β-hairpin mimetic peptide and generated cyclic nNOS β-hairpin peptide arrays with natural and unnatural amino acids (AAs), which provided molecular insights into this interaction. We then optimized cyclic peptides and identified a potent inhibitor of the nNOS/PSD-95 interaction, with the highest affinity reported thus far for a peptide macrocycle inhibitor of PDZ domains, which serves as a template for the development of treatment for acute ischemic stroke.
PubMed: 36580549
DOI: 10.1021/acs.jmedchem.2c01803
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.59 Å)
Structure validation

227344

数据于2024-11-13公开中

PDB statisticsPDBj update infoContact PDBjnumon